BIG
ORKA

Brookwood Investment Group’s Oruka Therapeutics ORKA Stock Holding History

Brookwood Investment Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
12,990
-3,003
-19% -$200K 0.14% 157
2026
Q1 		$784K Sell
15,993
-576
-3% -$20K 0.1% 197
2025
Q4 		$502K Buy
+16,569
New +$462K 0.06% 287

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Brookwood Investment Group's ORKA Position: Q2 2026 in Review

Brookwood Investment Group reduced its Oruka Therapeutics (ORKA) stake by 19% in Q2 2026, selling an estimated $200K and leaving 12,990 shares worth $1.24M. The position accounts for 0.14% of the portfolio, ranked #157.

Brookwood Investment Group first reported a position in ORKA in Q4 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Brookwood Investment Group held 12,990 shares of Oruka Therapeutics worth $1.24M as of Q2 2026.
  • Brookwood Investment Group sold 3,003 Oruka Therapeutics shares in Q2 2026, an estimated $200K.
  • Oruka Therapeutics made up 0.14% of Brookwood Investment Group's portfolio in Q2 2026, its #157 holding.
  • Brookwood Investment Group first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.